Article

Lysophosphatidic acid and lysophosphatidylcholine levels in serum samples of patients with major depressive disorder

2020-10-06

Abstract excerpt

<h4>ABSTRACT</h4> Major depressive disorder (MDD) is a heterogeneous condition featured with a continuous low mood, feeling of sadness, lack of interest to perform daily activities. Many factors including genetic, physiological, biological, social, and environmental are thought to be connected with the pathophysiology of depression. Several previous studies failed to identify the favorable biomarkers for MDD. Lyso...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1a84fbb0-4db8-510e-bf4f-8a7e6392819c
DOI: 10.1101/2020.10.04.20206490

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lysophosphatidic acid and lysophosphatidylcholine levels in serum samples of patients with major depressive disorderDOI 10.1101/2020.10.04.20206490Read

Advances in biomarkers of major depressive disorder.Semantic proximity Read

The Metabolome-Wide Signature of Major Depressive DisorderSemantic proximity Read

Transformations in Plasma Metabolic Profiles of Patients with Major Depression During Treatment: A Pilot Metabolomics StudySemantic proximity Read

A review of new insights into existing major depressive disorder biomarkersSemantic proximity Read

The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk.Semantic proximity Read

Deep Lipidomic Phenotyping Identifies Ceramide-Centered Lipotoxicity and Depletion of Plasmalogen-Carnitine Pathways in Major Depressive Disorder: Implications for Precision MedicineSemantic proximity Read

Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and AdolescentsSemantic proximity Read

The contribution of proteomic studies in humans, animal models, and after antidepressant treatments to investigate the molecular neurobiology of major depressionSemantic proximity Read

Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studiesSemantic proximity Read

From Depression-Associated Phospholipid Remodeling to Receptor-Active Lipid Signaling: The LPC-ATX-LPA Axis as a Testable FrameworkSemantic proximity Read

Prevalence and correlates of severe anxiety in patients with first hospitalization for major depressive disorder combined with dyslipidemia: a large sample cross-sectional studySemantic proximity Read

Genetic Association of Butyrylcholinesterase with Major Depressive Disorder.Semantic proximity Read